Physician

Charles Andrew Gilliland, MD

According to 2025 Medicare claims, Charles Gilliland, MD (NPI: 1366646192) practices sports medicine in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Lawrence, OH. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1053643981; TIN: 264183569) and primary practice location at 41101-2880. Gilliland is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Gilliland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 287 traditional Medicare patients, billed 751 HCPCS/CPT codes, and received $29,202 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 200 prescription claims across 131 beneficiaries totaling $2,290 in drug costs, led by Celecoxib (Celecoxib). DME data shows 43 claims. Open Payments data shows 2 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $109,132 to $29,202. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	348	1,869	$109,132
2016	369	1,610	$92,889
2017	302	1,241	$69,700
2018	324	911	$44,019
2019	337	782	$36,136
2020	334	823	$31,961
2021	317	787	$34,568
2022	251	945	$25,886
2023	270	880	$25,415
2024	287	751	$29,202

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	123	$2,138
2016	86	133	$1,516
2017	83	138	$4,241
2018	76	120	$3,589
2019	119	195	$6,276
2020	127	232	$5,416
2021	93	136	$4,095
2022	107	156	$3,152
2023	108	151	$3,161
2024	131	200	$2,290

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	23	24	$4,130
2020	63	65	$10,492
2021	47	48	$5,394
2022	20	22	$1,805
2023	35	39	$4,656
2024	26	43	$2,335

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	71	71	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	54	$67
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	127	128	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	124	$46
20610	Aspiration and/or injection of fluid from large joint	62	69	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	78	2,598	$1,473
Methylprednisolone	Methylprednisolone	49	294	$249
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	201	$162

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L1812	Knee orthosis, elastic with joints, prefabricated, off-the-shelf	N	15	15	$1,189
L2999	Lower extremity orthoses, not otherwise specified	N	11	11	$914
E0149	Walker, heavy duty, wheeled, rigid or folding, any type	Y	N/R	17	$231

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$30	DePuy Synthes Sales Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Andrew Gilliland, MD?

Tedicare shows public-source Medicare data for Charles Andrew Gilliland, MD (NPI 1366646192), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Andrew Gilliland, MD have ACO affiliation data?

Charles Andrew Gilliland, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Charles Andrew Gilliland, MD?

Charles Andrew Gilliland, MD is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1053643981) in the available physician profile data.

Does Charles Andrew Gilliland, MD have Open Payments data?

Charles Andrew Gilliland, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.